Ad is loading...
PQIRX
Price
$35.76
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

PQIRX vs VVIAX

Header iconPQIRX vs VVIAX Comparison
Open Charts PQIRX vs VVIAXBanner chart's image
Pioneer Equity Income R
Price$35.76
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PQIRX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PQIRX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PQIRX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. PQIRX (1.06B). VVIAX pays higher dividends than PQIRX: VVIAX (2.36) vs PQIRX (1.09). PQIRX was incepted earlier than VVIAX: PQIRX (22 years) vs VVIAX (24 years). PQIRX is a more actively managed with annual turnover of: 59.00 vs. VVIAX (10.00). PQIRX has a lower initial minimum investment than VVIAX: PQIRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. PQIRX (4.81). VVIAX return over 5 years is better than : 53.09 vs. PQIRX (1.98).
PQIRXVVIAXPQIRX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD14.92819.67276%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B184B1%
Annual Yield % from dividends1.092.3646%
Returns for 1 year4.8126.0918%
Returns for 3 years-16.9124.77-68%
Returns for 5 years1.9853.094%
Returns for 10 years14.55112.2613%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics